BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22673527)

  • 21. The opsoclonus–myoclonus syndrome.
    Sahu JK; Prasad K
    Pract Neurol; 2011 Jun; 11(3):160-6. PubMed ID: 21551110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroblastoma in a Neonate: A Case Report.
    Jnah AJ; Evans SK; Sewell K; Trembath A
    Neonatal Netw; 2019 Nov; 38(6):341-347. PubMed ID: 31712398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroblastoma models for insights into tumorigenesis and new therapies.
    Kiyonari S; Kadomatsu K
    Expert Opin Drug Discov; 2015 Jan; 10(1):53-62. PubMed ID: 25345447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroblastoma and opsoclonus-myoclonus-ataxia syndrome--clinical and pathological characteristics.
    Stefanowicz J; Izycka-Swieszewska E; Drozyńska E; Pienczk J; Połczyńska K; Czauderna P; Sierota D; Bień E; Stachowicz-Stencel T; Kosiak W; Balcerska A
    Folia Neuropathol; 2008; 46(3):176-85. PubMed ID: 18825593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroblastoma.
    Matthay KK; Maris JM; Schleiermacher G; Nakagawara A; Mackall CL; Diller L; Weiss WA
    Nat Rev Dis Primers; 2016 Nov; 2():16078. PubMed ID: 27830764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
    Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
    Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes in multifocal neuroblastoma as part of the neurocristopathy syndrome.
    Williams P; Wegner E; Ziegler DS
    Pediatrics; 2014 Aug; 134(2):e611-6. PubMed ID: 25070313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour].
    Jamroz E; Głuszkiewicz E; Madziara W; Kiełtyka A
    Med Wieku Rozwoj; 2011; 15(2):151-6. PubMed ID: 22002047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal neuroblastomas. Diagnosis, treatment, and prognosis.
    Balakrishnan V; Rice MS; Simpson DA
    J Neurosurg; 1974 May; 40(5):631-8. PubMed ID: 4817808
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome.
    Brunklaus A; Pohl K; Zuberi SM; de Sousa C
    Arch Dis Child; 2012 May; 97(5):461-3. PubMed ID: 21460401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal diagnosis of dumbbell neuroblastoma.
    Delahaye S; Doz F; Sonigo P; Saada J; Mitanchez D; Sarnacki S; Benachi A
    Ultrasound Obstet Gynecol; 2008 Jan; 31(1):92-5. PubMed ID: 18058843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management strategy in neuroblastoma].
    Balwierz W
    Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.
    De Bernardi B; Gerrard M; Boni L; Rubie H; Cañete A; Di Cataldo A; Castel V; Forjaz de Lacerda A; Ladenstein R; Ruud E; Brichard B; Couturier J; Ellershaw C; Munzer C; Bruzzi P; Michon J; Pearson AD
    J Clin Oncol; 2009 Mar; 27(7):1034-40. PubMed ID: 19171711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activating mutations in ALK provide a therapeutic target in neuroblastoma.
    George RE; Sanda T; Hanna M; Fröhling S; Luther W; Zhang J; Ahn Y; Zhou W; London WB; McGrady P; Xue L; Zozulya S; Gregor VE; Webb TR; Gray NS; Gilliland DG; Diller L; Greulich H; Morris SW; Meyerson M; Look AT
    Nature; 2008 Oct; 455(7215):975-8. PubMed ID: 18923525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
    Chang BH; Koch T; Hopkins K; Malempati S
    Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
    Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
    Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroblastoma: an unusual presentation with bilateral ptosis.
    Tatli B; Saribeyoğlu ET; Aydinli N; Calişkan M; Anak S
    Pediatr Neurol; 2004 Apr; 30(4):284-6. PubMed ID: 15087109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.
    Spitz R; Betts DR; Simon T; Boensch M; Oestreich J; Niggli FK; Ernestus K; Berthold F; Hero B
    Cancer Genet Cytogenet; 2006 May; 167(1):51-6. PubMed ID: 16682287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroblastoma: biology and therapy.
    Matthay KK
    Oncology (Williston Park); 1997 Dec; 11(12):1857-66; discussion 1869-72, 1875. PubMed ID: 9436190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Features and outcomes of neonatal neuroblastoma.
    Kostyrka B; Li J; Soundappan SV; Cassey J; Alvaro F; Dalla Pozza L; Kumar R
    Pediatr Surg Int; 2011 Sep; 27(9):937-41. PubMed ID: 21710243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.